Payne John Bernard
- SEC CIK
- 0001582392
In the past year, 1 open-market purchase filing worth $100.0K and no sales.
Current role at each company
- ZIVO Zivo Bioscience, Inc.President and CEOas of Jan 28, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- $100.0K
- 1 filing
- Sold
- –
- 0 filings
- Net
- +$100.0K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Payne John Bernard as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jan 28, 2026 (view filing) | Jan 26 | 2 days | Payne John BernardPresident and CEO | PPurchase | +11.7K | $8.54 | +$100.0K | +148.0%19.6K after | |
| Oct 16, 2024 (view filing) | Oct 16 | Same day | Payne John BernardPresident and CEO | PPurchase | +6.34K | $15.76 | +$100.0K | +405.0%7.91K after | |
| Oct 16, 2024 (view filing) | Oct 16 | Same day | Payne John BernardPresident and CEO | PPurchase | +634 | $15.77 | +$10.0K | –634 after | Derivative |
| Apr 5, 2023 (view filing) | Apr 3 | 2 days | Payne John BernardPresident and CEO | PPurchase | +390.0K | – | – | –390.0K after | Derivative |
| Dec 20, 2022 (view filing) | Dec 19 | 1 day | Payne John BernardPresident and CEO | PPurchase | +57 | $2.50 | +$142.5 | +0.6%9.40K after | |
| Jan 28, 2022 (view filing) | Jan 25-27 | 3 daysLate | Payne John BernardDirector | PPurchase | +9.17K | $2.50 | +$22.9K | +5,209.1%9.34K after | 2 lots |